Who owns CYCLO THERAPEUTICS INC?
- Ticker: CYTH
- CUSIP Number: 23254x201
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cyclo Therapeutics stock
Who bought or sold CYCLO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Founders Fund V Management | 481k | $668M | 0% | Mar 2024 |
|
| Vanguard Group | 397k | $551k | 12% | Mar 2024 |
|
| Geode Capital Management | 160k | $222k | 59% | Mar 2024 |
|
| Founders Fund VI Management | 110k | $153k | 0% | Mar 2024 |
|
| BlackRock | 37k | $52k | 10156% | Mar 2024 |
|
| Northern Trust | 22k | $30k | 31% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 20k | $28k | 10% | Mar 2024 |
|
| Tower Research Capital | 6.6k | $9.1k | -3% | Mar 2024 |
|
| UBS Group | 4.8k | $6.7k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 4.6k | $6.3k | 91% | Mar 2024 |
|
| Princeton Global Asset Management | 3.8k | $5.2k | 1155% | Mar 2024 |
|
| Morgan Stanley | 1.0k | $1.4k | 151% | Mar 2024 |
|
| Royal Bank of Canada | 746.00 | $1.0k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 153.00 | $213.006600 | 750% | Mar 2024 |
|
| Steward Partners Investment Advisory | 90.00 | $125.001000 | 0% | Mar 2024 |
|
| Advisor Group Holdings | 67.00 | $93.002700 | -89% | Mar 2024 |
|
| Bank of America Corporation | 27.00 | $37.999800 | 93% | Mar 2024 |
|
| Qube Research & Technologies | 21.00 | $29.001000 | 100% | Mar 2024 |
|
Who sold out of Cyclo Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 54k | $86k |
| XTX Topco | Sep 2023 | 13k | $18k |
| Virtu Financial | Sep 2023 | 11k | $15k |
| Simplex Trading | Dec 2023 | 200.00 | $0 |
| New York State Common Retirement Fund | Dec 2023 | 113.00 | $0 |